XML 50 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Share Capital (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Equity [Abstract]    
Summary of Stock Option Activity

A summary of the Company’s option activity related to options to employees and directors, and related information is as follows:

    For the nine months ended September 30, 2018  
   

Number of

stock options

    Weighted average exercise price    

Aggregate

intrinsic value

 
                   
Outstanding at beginning of period     414,965     $ 11.70     $ 1,859  
Granted     10,000       9       -  
Exercised     (2,487)       -       -  
Cancelled     -       -       -  
Outstanding at end of period     422,478     $ 11.70     $ 729  
Vested and expected-to-vest at end of period     228,758     $ 7.80     $ 729  

 

    For the year ended December 31, 2017(*)  
    Number of stock options     Weighted average exercise price     Aggregate intrinsic value  
Outstanding at beginning of period     174,328     $ 1.95     $ 3,739  
Granted     272,090       16.50       -  
Exercised     (31,453)       -       -  
Cancelled     -       -       -  
Outstanding at end of period     414,965     $ 11.70     $ 1,859  
Vested and expected-to-vest at end of period     142,875     $ 1.95     $ 1,375  

 

(*) December 31, 2017 options data represents the number of shares adjusted to retroactively reflect the 1:15 Reverse Split effected on September 4, 2018.

A summary of the Company’s option activity related to options to employees and directors, and related information is as follows:

 

   

For the year ended

December 31, 2017(**)

 
    Number of stock options     Weighted average exercise price     Aggregate intrinsic value  
                   
Outstanding at beginning of period     174,328     $ 1.95     $ 3,739  
Granted     272,090       16.5       -  
Exercised     (31,453 )     -       -  
Cancelled     -       -       -  
      414,965     $ 11.7     $ 1,859  
Outstanding at end of period     142,875     $ 1.95     $ 1,375  
Vested and expected-to-vest at end of period     174,328     $ 1.95     $ 3,739  

 

   

For the year ended

December 31, 2016(**)

 
    Number of stock options     Weighted average exercise price     Aggregate intrinsic value  
                   
Outstanding at beginning of period     77,846     $ 4.2       -  
Granted     96,482       (*)       -  
Exercised     -       -       -  
Cancelled     -       -       -  
                         
Outstanding at end of period     174,328     $ 1.95     $ 15,624  
Vested and expected-to-vest at end of period     174,328     $ 1.95     $ 15,624  

 

 

(*) Less than 1

(**) December 31 2017 and 2016 options data represents the number of shares adjusted to retroactively reflect the 1:15 Reverse Split effected on September 4, 2018.

Schedule of Stock Options Outstanding

The stock options outstanding as of September 30, 2018 and December 31, 2017, separated by exercise prices, are as follows:

 

Exercise

price

$

    Stock options outstanding as of September 30, 2018     Stock options outstanding as of December 31, 2017(**)     Weighted average remaining contractual life – years as of September 30, 2018     Weighted average remaining contractual life – years as of December 31, 2017(**)     Stock options exercisable as of September 30, 2018     Stock options exercisable as of December 31, 2017(**)  
                                       
  4.20       77,846       77,846       7.25       8.00       77,846       77,846  
  15.75       133,546       133,546       9.00       9.75       46,117       -  
  9.00       10,000       -       10.00       -       -       -  
  19.35       72,508       72,508       9.00       9.75       23,565       -  
  15.30       66,036       66,036       9.25       10.00       18,688       -  
  (*)       62,542       65,029       8.00       8.75       62,542       65,029  
          422,478       414,965       8.55       9.3       228,758       142,875  

 

 

  (*) Less than $0.01.
  (**) December 31, 2017 options data represents the number of shares adjusted to retroactively reflect the 1:15 Reverse Split effected on September 4, 2018.

The stock options outstanding as of December 31, 2017 and December 31, 2016, separated by exercise prices, are as follows:

 

Exercise price    

Stock options outstanding

as of December 31, (**)

   

Weighted average remaining contractual life – years as of

December 31, (**)

    Stock options exercisable as of December 31, (**)  
$     2017     2016     2017     2016     2017     2016  
                                       
  4.2       77,846       77,846       8.0       8.0       77,846       77,846  
  15.75       133,546       -       9.75       -       -       -  
  19.35       72,508       -       9.75       -       -       -  
  15.3       66,036       -       10       -       -       -  
  (* )     65,029       96,482       8.75       9.5       65,029       96,482  
          414,965       174,328       -       -       142,875       174,328  

 

 

(*) Less than 1

(**) December 31 2017 and 2016 options data represents the number of shares adjusted to retroactively reflect the 1:15 Reverse Split effected on September 4, 2018.

Schedule of Stock Options Valuation Assumptions

The fair value of the stock options is estimated at the date of grant using Black-Scholes options pricing model with the following weighted-average assumptions:

 

    Nine months ended September 30, 2018     Year ended
December 31, 2017
 
Expected volatility     99.4%       122.5%  
Risk-free interest     2.39%       1.64%  
Dividend yield     0%       0%  
Expected life of up to (years)     5.24       6.25  

The fair value of the stock options is estimated at the date of grant using Black-Scholes options pricing model with the following weighted-average assumptions:

 

    Years ended December 31,  
    2017     2016  
             
Expected volatility     122.5 %     77.3 %
Risk-free interest     1.64 %     0.6 %
Dividend yield     0 %     0 %
Expected life of up to (years)     6.25       5.0